Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Local biotech startup Cour Pharmaceuticals has signed a ...
CHICAGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies to treat autoimmune diseases, today announced that ...
Cour Pharmaceuticals, the Chicago-based clinical-stage biotechnology company, says its first patient has been dosed in the phase 1b/2a clinical trial of a treatment that it hopes will address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback